Related content

Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide

By              

International Journal of Oncology, Vol. 42, Iss. 3, 2013-01 ,pp. : 831-838

Spandidos Publications

Access to resources Recommend Favorite

Identification of HLA-A*0201-restricted cytotoxic T lymphocyte epitope from proliferating cell nuclear antigen

By Xu Wei  

Tumor Biology, Vol. 32, Iss. 1, 2011-02 ,pp. : 63-69

Springer Publishing Company

Access to resources Recommend Favorite

Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28

By Han Jun-Feng   Zhao Ting-Ting   Liu Hong-Li   Lin Zhi-Hua   Wang Hui-Ming   Ruan Zhi-Hua   Zou Li-Yun   Wu Yu-Zhang  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 12, 2006-12 ,pp. : 1575-1583

Springer Publishing Company

Access to resources Recommend Favorite

The cytotoxic T cell response to peptide analogs of the HLA-A*0201-restricted MUC1 signal sequence epitope, M1.2

By Mitchell Malcolm   Lund Teri   Sewell Andrew   Marincola Francesco   Paul Elyse   Schroder Kim   Wilson Darcy   Kan-Mitchell June  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 3, 2007-03 ,pp. : 287-301

Springer Publishing Company

Access to resources Recommend Favorite

Cytotoxic T lymphocyte-associated antigen 4 inhibition increases the antitumor activity of adoptive T-cell therapy when carried out with naïve rather than differentiated T cells

By                                

Oncology Reports, Vol. 33, Iss. 5, 2015-01 ,pp. : 2545-2552

Spandidos Publications

Access to resources Recommend Favorite